BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6365482)

  • 1. Enhancement of R-plasmid-determined resistance to aminoglycoside antibiotics by R-plasmid nitrofurantoin resistance in Escherichia coli.
    Obaseiki-Ebor EE; Gborikoko C
    Chemotherapy; 1984; 30(2):92-6. PubMed ID: 6365482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhancement of R-plasmid-mediated resistance to aminoglycoside antibiotics by mutations to nitrofurantoin resistance in Escherichia coli.
    Breeze AS; Obaseiki-Ebor EE
    J Antimicrob Chemother; 1984 Nov; 14(5):477-83. PubMed ID: 6392278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofuran reductase activity in nitrofurantoin-resistant strains of Escherichia coli K12: some with chromosomally determined resistance and others carrying R-plasmids.
    Breeze AS; Obaseiki-Ebor EE
    J Antimicrob Chemother; 1983 Dec; 12(6):543-7. PubMed ID: 6363380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations to nitrofurantoin and nitrofurazone resistance in Escherichia coli K12.
    Breeze AS; Obaseiki-Ebor EE
    J Gen Microbiol; 1983 Jan; 129(1):99-103. PubMed ID: 6339681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Escherichia coli susceptibility to nitrofurantoin by EDTA and multiple aminoglycoside antibiotics resistance mutation.
    Obaseiki-Ebor EE
    Chemotherapy; 1984; 30(2):88-91. PubMed ID: 6421551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of the combination of nitrofurantoin and trimethoprim against sensitive and nitrofurantoin and trimethoprim-resistant Escherichia coli K12.
    Obaseiki-Ebor EE
    Chemotherapy; 1985; 31(2):124-9. PubMed ID: 3886319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of nitrofuran reduction in Escherichia coli: evidence for their existence, partial purification, binding of nitrofurantoin in vitro, and implications for nitrofuran resistance.
    Sastry SS; Jayaraman R
    Arch Biochem Biophys; 1985 Jan; 236(1):252-9. PubMed ID: 3881084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):598-604. PubMed ID: 393165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chlorate- and streptomycin-resistance mutations on nitrofurantoin resistance in Escherichia coli K-12.
    Obaseiki-Ebor EE; Breeze AS
    Can J Microbiol; 1984 Dec; 30(12):1448-52. PubMed ID: 6395949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial drug resistance among Escherichia coli isolated from calves fed on a milk substitute diet.
    Hinton M; Linton AH
    Vet Rec; 1983 Jun; 112(24):567-8. PubMed ID: 6349103
    [No Abstract]   [Full Text] [Related]  

  • 14. Transferable nitrofuran resistance conferred by R-plasmids in clinical isolates of Escherichia coli.
    Breeze AS; Obaseiki-Ebor EE
    J Antimicrob Chemother; 1983 Nov; 12(5):459-67. PubMed ID: 6368515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent emergence of aminoglycoside-resistant Escherichia coli during neonatal meningitis.
    Echeverria P; Lew MA; Smith AL
    N Engl J Med; 1975 Oct; 293(18):913-4. PubMed ID: 1101060
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides.
    Sun H; Li S; Xie Z; Yang F; Sun Y; Zhu Y; Zhao X; Jiang S
    J Antimicrob Chemother; 2012 Jul; 67(7):1635-8. PubMed ID: 22499999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic modification of aminoglycoside antibiotics by Branhamella catarrhalis carrying an R factor.
    Robledano L; Rivera MJ; Otal I; Gómez-Lus R
    Drugs Exp Clin Res; 1987; 13(3):137-43. PubMed ID: 3304917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique aminoglycoside-O-phosphorylating activity mediating resistance to aminoglycosides in Escherichia coli.
    Santanam P; Maino L; Kayser FH
    J Antimicrob Chemother; 1985 Sep; 16(3):401-2. PubMed ID: 2997102
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of plasmid-mediated antibiotic resistances in Vibrio parahaemolyticus.
    Hasegawa H; Hamashima H; Arai T
    Microbiol Immunol; 1986; 30(5):437-44. PubMed ID: 3528768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial resistance to streptothricins.
    Haupt I; Thrum H
    J Basic Microbiol; 1985; 25(5):335-9. PubMed ID: 2993582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.